Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bonyf NVXPAR:MLBON 12 Days Payable is 432.91 as of Dec. 2024, which is 7% above its 10-year median of 405.33. GuruFocus rates XPAR:MLBON with a GF Score™ of 12/100 and a GF Value™ of €8.61 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Bonyf NV ranks better than 91.82% on this metric.
Bonyf NV's average Accounts Payable for the
six
months ended in Dec. 2024 was €0.31 Mil. Bonyf NV's Cost of Goods Sold for the
six
months ended in Dec. 2024 was €0.26 Mil.
Hence, Bonyf NV's Days Payable for the
six
months ended in Dec. 2024 was 216.45.
The historical rank and industry rank for Bonyf NV's Days Payable or its related term are showing as below:
XPAR:MLBON'
s Days Payable Range Over the Past 10 Years
Min: 84.77 Med: 405.33 Max: 432.91
Current: 432.91
During the past 5 years, Bonyf NV's highest Days Payable was 432.91. The lowest was 84.77. And the median was 405.33.
XPAR:MLBON's Days Payable is ranked better than 91.82% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs XPAR:MLBON: 432.91
Bonyf NV's Days Payable
increased
from Dec. 2022 (405.33) to Dec. 2024 (432.91).
It may suggest that Bonyf NVdelayed paying its suppliers.
The historical data trend for Bonyf NV's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bonyf NV Days Payable Chart
Bonyf NV Annual Data
Trend
Dec19
Dec20
Dec22
Dec23
Dec24
Days Payable
84.77
119.97
405.33
428.84
432.91
Bonyf NV Semi-Annual Data
Dec19
Dec20
Dec22
Dec23
Dec24
Days Payable
84.77
119.97
405.33
428.84
432.91
XPAR:MLBON vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Bonyf NV's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bonyf NV Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bonyf NV's Days Payable distribution charts can be found below:
* The bar in red indicates where Bonyf NV's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Bonyf NV's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bonyf NV (XPAR:MLBON) has a Days Payable of 432.91 as of Dec. 2024. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bonyf NV and its competitors. This is near median its historical median of 405.33. Over the past decade, Bonyf NV's Days Payable has ranged from 84.77 to 432.91. According to the industry distribution chart, Bonyf NV ranks #65 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 8.2%.
Is Bonyf NV's Days Payable too high?
Bonyf NV's current Days Payable of 432.91 is near median its 10-year median of 405.33. Over the past 10 years, this metric has ranged from a low of 84.77 to a high of 432.91. The Medical Devices & Instruments industry median Days Payable is 67.87. Bonyf NV's value of 432.91 is 537.9% above this industry median. Based on the distribution chart, Bonyf NV ranks #65 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Bonyf NV has a GF Score™ of 12/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bonyf NV's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bonyf NV ranks #65 out of 795 companies for Days Payable. This places Bonyf NV in the top 8% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.87. Bonyf NV's value of 432.91 is 537.9% above this benchmark. Historically, Bonyf NV's own Days Payable has ranged from 84.77 to 432.91 over the past decade. While the company's 10-year median is 405.33 vs. the industry median of 67.87, Bonyf NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bonyf NV's current Days Payable of 432.91 is 537.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bonyf NV and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bonyf NV's current Days Payable is 432.91, which is near median its own 10-year median of 405.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonyf NV stock overvalued right now?
Based on GuruFocus' analysis, Bonyf NV (XPAR:MLBON) is currently considered Possible Value Trap. The stock's GF Value™ is €8.61, compared to a current price of €2.48 — trading 71.2% below its estimated fair value. The current Days Payable is 432.91, which is near median its 10-year median of 405.33 and 537.9% above the Medical Devices & Instruments industry median of 67.87. Bonyf NV's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Bonyf NV (XPAR:MLBON), the current Days Payable is 432.91 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bonyf NV (XPAR:MLBON) Overvalued in 2026?
Based on GuruFocus' analysis, Bonyf NV stock appears to be undervalued.
The current stock price of €2.48 is trading 71.2% below its estimated GF Value™ of €8.61.
GuruFocus considers Bonyf NV to be Possible Value Trap.
Key valuation signals for XPAR:MLBON:
Days Payable: 432.91 (near median its 10-year median of 405.33)
GF Value™: €8.61 vs. price of €2.48 (71.2% below fair value)
Industry Position: 537.9% above the Medical Devices & Instruments median (#65 of 795)
No single metric tells the full story. See the XPAR:MLBON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bonyf NV specializes in developing, producing and selling cutting-edge oral & dental care products. It is a forward-thinking company committed to revolutionizing oral care through innovation and research.
12GF Score
Get the complete analysis for XPAR:MLBON
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLBON has been successfully added to your 
